Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer.

Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Abstract Text:

    shunzo maetaniShunzo Maetani,hisashi onoderaHisashi Onodera,toshikuni nishikawaToshikuni Nishikawa,shunzo maetaniShunzo Maetani,hisashi onoderaHisashi Onodera,toshikuni nishikawaToshikuni Nishikawa,

    PURPOSE: Survival benefit of radical surgery for locally recurrent rectal cancer depends on whether disease is cured rather than whether death is delayed. Cured patients gain decades of life and are spared from sufferings with recurrence. Unfortunately, the majority of patients undergoing surgery, particularly those with extrarectal pelvic recurrence, have poor outcomes with occult disseminated disease. This study was designed to identify which of these patients are curable. METHODS: Of 61 patients with pelvic recurrence treated by radical reexcision more than nine years before, 36 patients whose initial surgery was abdominoperineal resection were examined retrospectively. We used the logistic regression and Gamel-Boag regression models to estimate curability and identify predictors of cure. RESULTS: Ten patients survived five years and seven survived ten years. The cumulative disease-specific mortality curve leveled off 6.5 years after reexcision and remained at 74 percent (95 percent confidence interval, 60-89), indicating that the remaining 26 percent are curable. This value is comparable with the 23 percent curability estimated by the Gamel-Boag model, which also found that the disease-free interval from the initial surgery to the first recurrence is the best predictor of cure (P = 0.005). Of 11 patients with disease-free interval three years or more, 6 survived ten years, whereas 8 of 9 patients with disease-free interval less than one year died of second recurrence within three years of reexcision. CONCLUSIONS: Even patients with extrarectal pelvic recurrence may have isolated disease that is amenable to complete eradication. As a biologic marker, the disease-free interval serves to predict curability and may distinguish isolated disease from occult disseminated disease.

    Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Publishing Authors By Initials

    s maetaniS Maetani,h onoderaH Onodera,t nishikawaT Nishikawa,s maetaniS Maetani,h onoderaH Onodera,t nishikawaT Nishikawa,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Diseases of the colon and rectum

    VOLUME: 50

    Page Numbers: 1558-65; discussion 1565-7

    Journal Abbreviation: Dis. Colon Rectum

    ISSN: 0012-3706

    DAY: 15

    MONTH: Oct

    YEAR: 2007

    Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372764

    Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer.

    AFFILIATION: Tenri Institute of Medical Research, 200 Mishima-cho, Tenri, Japan. maetani@tenriyorozu-hp.or.jp

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Dis Colon Rectum

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News